About the RNA Therapeutics For Cancer Session
RNA therapeutics represent a promising frontier in cancer research, offering targeted treatment options with potential for fewer side effects. These therapies utilize various RNA molecules, including messenger RNA (mRNA), small interfering RNA (siRNA), and microRNA (miRNA), to regulate gene expression or directly target cancer cells. mRNA vaccines, like those developed for COVID-19, stimulate the immune system to recognize and attack cancer-specific antigens. siRNA molecules can silence oncogenes or block proteins essential for tumor growth. Additionally, miRNAs regulate gene expression and control cellular processes implicated in cancer progression. By harnessing the power of RNA, researchers aim to develop precise, personalized treatments that disrupt cancer pathways while sparing healthy tissues. As this field advances, RNA therapeutics hold immense potential to revolutionize cancer care, offering hope for more effective and tailored treatment strategies.
Topics Covered in RNA Therapeutics For Cancer
Messenger RNA Vaccines
Small Interfering RNA
MicroRNA Modulation
Antisense Oligonucleotides
Lipid Nanoparticle Delivery
Off-Target Effects
Related Scientific Sessions at CIOC 2027
Why Attend the RNA Therapeutics For Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original RNA Therapeutics For Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping RNA Therapeutics For Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the RNA Therapeutics For Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
RNA Therapeutics For Cancer Conference 2027 — FAQs
What is the RNA Therapeutics For Cancer track at CIOC 2027?
The RNA Therapeutics For Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in RNA Therapeutics For Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the RNA Therapeutics For Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in RNA Therapeutics For Cancer are all welcome — whether presenting or attending.
Can I present my research in the RNA Therapeutics For Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for RNA Therapeutics For Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the RNA Therapeutics For Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.